×

Anti-CD79B antibodies and immunoconjugates and methods of use

  • US 8,545,850 B2
  • Filed: 11/05/2010
  • Issued: 10/01/2013
  • Est. Priority Date: 07/16/2007
  • Status: Expired
First Claim
Patent Images

1. An immunoconjugate comprising an anti-CD79b antibody comprising:

  • (i) an HVR-L1 sequence of KASQSVDYEGDSFLN (SEQ ID NO;

         194)(ii) an HVR-L2 sequence of AASNLES (SEQ ID NO;

         195)(iii) an HVR-L3 sequence of QQSNEDPLT (SEQ ID NO;

         196)(iv) an HVR-H1 sequence of GYTFSSYWIE (SEQ ID NO;

         202)(v) an HVR-H2 sequence of GEILPGGGDTNYNEIFKG (SEQ ID NO;

         203), and(vi) an HVR-H3 sequence of TRRVPIRLDY (SEQ ID NO;

         204),wherein said antibody is covalently attached to a cytotoxic agent.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×